Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 19/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6491342 | 0.88 | GHSR (0.53) | GHSROPRM1ACE | |
| SCHEMBL8792189 | 0.88 | GHSR (0.53) | GHSROPRM1ACE | |
| SCHEMBL6488832 | 0.88 | MMP9 (0.43) | GHSROPRM1ACE | |
| SCHEMBL6483067 | 0.86 | HPGDS (0.44) | ACE | |
| SCHEMBL6490489 | 0.83 | MEN1 (0.43) | — | |
| SCHEMBL6481850 | 0.82 | MEN1 (0.45) | GHSR | |
| SCHEMBL6481196 | 0.82 | MMP9 (0.43) | — | |
| SCHEMBL6496156 | 0.80 | GHSR (0.34) | GHSR | |
| SCHEMBL8790279 | 0.80 | MAPT (0.46) | GHSROPRM1 | |
| SCHEMBL6480725 | 0.80 | CA12 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | ELIXIR PHARMACEUTICALS, INC. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | GLS2, STS, ABAT | GHSR 3083/4885OPRM1 4535/4885ACE 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.